Target intelligence / Profile preview

Clostridioides difficile cell-surface antigens and lysate components

Molecular classification
Bacterial antigen complex, Other
01

Overview

Clostridioides difficile cell-surface antigens and lysate components comprise a diverse array of molecular targets found on the surface and within the vegetative cells and spores of the bacterium Clostridioides difficile. These targets include surface-layer proteins (SLPs), cell wall proteins (Cwps), flagellar components, and various intracellular proteins released during cell lysis, alongside the critical virulence factor Toxin B (TcdB). Biologically, these components are vital for the bacterium's lifecycle, facilitating adherence to the intestinal mucosa, colonization of the gut, and the initiation of inflammatory processes through toxin secretion. In clinical settings, C. difficile is the primary cause of antibiotic-associated diarrhea and can lead to severe conditions such as pseudomembranous colitis and toxic megacolon. Therapeutic interventions, such as the oral polyclonal antibody IMM-529, are designed to target this broad spectrum of antigens to neutralize toxins and inhibit bacterial colonization. By addressing multiple stages of the infection cycle, these therapies aim to treat active disease and prevent the high rates of recurrence characteristic of C. difficile infections while sparing the host's beneficial gut microbiota.

Other names
C. difficile surface antigensC. difficile whole-cell lysateC. difficile vegetative cell antigensC. difficile spore and cell antigensClostridioides difficile antigens
02

Mechanism of action

Polyclonal antibody-mediated neutralization of toxins (specifically Toxin B), inhibition of bacterial adhesion to intestinal epithelium, and prevention of spore-mediated colonization and germination.

03

Biological functions

AdhesionColonizationVirulenceToxin productionSpore germination
04

Disease associations

InfectionClostridioides difficile infection (CDI)DiarrheaColitis
05

Safety considerations

Allergic reactions to bovine-derived proteinsPotential for lack of efficacy in severe systemic disease due to oral administrationTherapeutic challenge of ensuring broad cross-reactivity across diverse hypervirulent strains
06

Interacting drugs

IMM-529
07

Biomarkers

Anti-C. difficile IgG titersAnti-C. difficile IgA titersToxin B levelsC. difficile colonization levels

Beyond the preview

Go deeper on Clostridioides difficile cell-surface antigens and lysate components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile cell-surface antigens and lysate components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call